Global Peanut Allergy Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Peanut Allergy Therapeutics market is projected to reach US$ 6416.9 million by 2028 from an estimated US$ 953.7 million in 2022, at a CAGR of 37.4% during 2023 and 2028.

United States is the largest consumption place, with a consumption market share nearly 45% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 31%.

Market competition is intense. Mylan, Bayer, UCB Pharma, J & J, Perrigo,top 5 players took 52% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peanut Allergy Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Peanut Allergy Therapeutics.

The Peanut Allergy Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Peanut Allergy Therapeutics market comprehensively. Regional market sizes, concerning products by type, by distribution channel, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peanut Allergy Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, distribution channel, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Mylan

Bayer

UCB Pharma

J & J

Perrigo

GSK

Kaleo

Amneal Pharma

ALK Abello

Aimmune Therapeutics

HUAPONT Pharm

Allergy Therapeutics

ASIT Biotech

Sanofi

DBV Technologies

HAL Allergy

Intrommune Therapeutics

Product Type Insights

Global markets are presented by Peanut Allergy Therapeutics type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Peanut Allergy Therapeutics are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Epinephrine Injection

Antihistamines

Oral Immunotherapy

Other

Application Insights

This report has provided the market size (revenue data) by distribution channel, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Peanut Allergy Therapeutics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Peanut Allergy Therapeutics market.

Peanut Allergy Therapeutics Segment by Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Peanut Allergy Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Peanut Allergy Therapeutics industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics.

1.1 Peanut Allergy Therapeutics Product Introduction

1.2 Market by Type

1.2.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Epinephrine Injection

1.2.3 Antihistamines

1.2.4 Oral Immunotherapy

1.2.5 Other

1.3 Market by Distribution Channel

1.3.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by Distribution Channel (2017 VS 2021 VS 2028)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

2.1 Global Peanut Allergy Therapeutics Market Size Estimates and Forecasts

2.2 Peanut Allergy Therapeutics Market Size by Region: 2022 Versus 2028

2.2.1 Global Peanut Allergy Therapeutics Revenue by Region: 2017-2022

2.2.2 Global Peanut Allergy Therapeutics Revenue Forecast by Region (2023-2028)

2.2.3 Global Peanut Allergy Therapeutics Revenue Market Share by Region (2017-2028)

3.1 Global Peanut Allergy Therapeutics Revenue by Company (2017-2022)

3.2 Global Peanut Allergy Therapeutics Revenue Share by Company (2017-2022)

3.3 Competitive Landscape

3.3.1 Key Peanut Allergy Therapeutics Companies around the World: Ranking by Revenue

3.3.2 Global Peanut Allergy Therapeutics Market Concentration Ratio (CR5 and HHI) & (2017-2022)

3.3.3 Global Peanut Allergy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.4 Global Peanut Allergy Therapeutics Companies Headquarters & Product Type

3.4.1 Peanut Allergy Therapeutics Companies Headquarters

3.4.2 Global Peanut Allergy Therapeutics Companies Product & Service

3.4.3 Date of International Companies Enter into Peanut Allergy Therapeutics Market

3.5 Global Peanut Allergy Therapeutics Mergers & Acquisitions, Expansion Plans

4.1 Mylan

4.1.1 Mylan Corporation Information

4.1.2 Mylan Description, Business Overview

4.1.3 Mylan Peanut Allergy Therapeutics Products Offered

4.1.4 Mylan Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.1.5 Mylan Peanut Allergy Therapeutics Revenue by Product in 2021

4.1.6 Mylan Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.1.7 Mylan Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.1.8 Mylan Recent Developments

4.2 Bayer

4.2.1 Bayer Corporation Information

4.2.2 Bayer Description, Business Overview

4.2.3 Bayer Peanut Allergy Therapeutics Products Offered

4.2.4 Bayer Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.2.5 Bayer Peanut Allergy Therapeutics Revenue by Product in 2021

4.2.6 Bayer Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.2.7 Bayer Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.2.8 Bayer Recent Developments

4.3 UCB Pharma

4.3.1 UCB Pharma Corporation Information

4.3.2 UCB Pharma Description, Business Overview

4.3.3 UCB Pharma Peanut Allergy Therapeutics Products Offered

4.3.4 UCB Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.3.5 UCB Pharma Peanut Allergy Therapeutics Revenue by Product in 2021

4.3.6 UCB Pharma Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.3.7 UCB Pharma Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.3.8 UCB Pharma Recent Developments

4.4 J & J

4.4.1 J & J Corporation Information

4.4.2 J & J Description, Business Overview

4.4.3 J & J Peanut Allergy Therapeutics Products Offered

4.4.4 J & J Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.4.5 J & J Peanut Allergy Therapeutics Revenue by Product in 2021

4.4.6 J & J Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.4.7 J & J Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.4.8 J & J Recent Developments

4.5 Perrigo

4.5.1 Perrigo Corporation Information

4.5.2 Perrigo Description, Business Overview

4.5.3 Perrigo Peanut Allergy Therapeutics Products Offered

4.5.4 Perrigo Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.5.5 Perrigo Peanut Allergy Therapeutics Revenue by Product in 2021

4.5.6 Perrigo Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.5.7 Perrigo Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.5.8 Perrigo Recent Developments

4.6 GSK

4.6.1 GSK Corporation Information

4.6.2 GSK Description, Business Overview

4.6.3 GSK Peanut Allergy Therapeutics Products Offered

4.6.4 GSK Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.6.5 GSK Peanut Allergy Therapeutics Revenue by Product in 2021

4.6.6 GSK Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.6.7 GSK Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.6.8 GSK Recent Development

4.7 Kaleo

4.7.1 Kaleo Corporation Information

4.7.2 Kaleo Description, Business Overview

4.7.3 Kaleo Peanut Allergy Therapeutics Products Offered

4.7.4 Kaleo Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.7.5 Kaleo Peanut Allergy Therapeutics Revenue by Product in 2021

4.7.6 Kaleo Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.7.7 Kaleo Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.7.8 Kaleo Recent Development

4.8 Amneal Pharma

4.8.1 Amneal Pharma Corporation Information

4.8.2 Amneal Pharma Description, Business Overview

4.8.3 Amneal Pharma Peanut Allergy Therapeutics Products Offered

4.8.4 Amneal Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.8.5 Amneal Pharma Peanut Allergy Therapeutics Revenue by Product in 2021

4.8.6 Amneal Pharma Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.8.7 Amneal Pharma Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.8.8 Amneal Pharma Recent Development

4.9 ALK Abello

4.9.1 ALK Abello Corporation Information

4.9.2 ALK Abello Description, Business Overview

4.9.3 ALK Abello Peanut Allergy Therapeutics Products Offered

4.9.4 ALK Abello Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.9.5 ALK Abello Peanut Allergy Therapeutics Revenue by Product in 2021

4.9.6 ALK Abello Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.9.7 ALK Abello Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.9.8 ALK Abello Recent Development

4.10 Aimmune Therapeutics

4.10.1 Aimmune Therapeutics Corporation Information

4.10.2 Aimmune Therapeutics Description, Business Overview

4.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Products Offered

4.10.4 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.10.5 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue by Product in 2021

4.10.6 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.10.7 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.10.8 Aimmune Therapeutics Recent Development

4.11 HUAPONT Pharm

4.11.1 HUAPONT Pharm Corporation Information

4.11.2 HUAPONT Pharm Description, Business Overview

4.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Products Offered

4.11.4 HUAPONT Pharm Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.11.5 HUAPONT Pharm Peanut Allergy Therapeutics Revenue by Product in 2021

4.11.6 HUAPONT Pharm Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.11.7 HUAPONT Pharm Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.11.8 HUAPONT Pharm Recent Development

4.12 Allergy Therapeutics

4.12.1 Allergy Therapeutics Corporation Information

4.12.2 Allergy Therapeutics Description, Business Overview

4.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Products Offered

4.12.4 Allergy Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.12.5 Allergy Therapeutics Peanut Allergy Therapeutics Revenue by Product in 2021

4.12.6 Allergy Therapeutics Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.12.7 Allergy Therapeutics Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.12.8 Allergy Therapeutics Recent Development

4.13 ASIT Biotech

4.13.1 ASIT Biotech Corporation Information

4.13.2 ASIT Biotech Description, Business Overview

4.13.3 ASIT Biotech Peanut Allergy Therapeutics Products Offered

4.13.4 ASIT Biotech Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.13.5 ASIT Biotech Peanut Allergy Therapeutics Revenue by Product in 2021

4.13.6 ASIT Biotech Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.13.7 ASIT Biotech Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.13.8 ASIT Biotech Recent Development

4.14 Sanofi

4.14.1 Sanofi Corporation Information

4.14.2 Sanofi Description, Business Overview

4.14.3 Sanofi Peanut Allergy Therapeutics Products Offered

4.14.4 Sanofi Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.14.5 Sanofi Peanut Allergy Therapeutics Revenue by Product in 2021

4.14.6 Sanofi Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.14.7 Sanofi Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.14.8 Sanofi Recent Development

4.15 DBV Technologies

4.15.1 DBV Technologies Corporation Information

4.15.2 DBV Technologies Description, Business Overview

4.15.3 DBV Technologies Peanut Allergy Therapeutics Products Offered

4.15.4 DBV Technologies Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.15.5 DBV Technologies Peanut Allergy Therapeutics Revenue by Product in 2021

4.15.6 DBV Technologies Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.15.7 DBV Technologies Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.15.8 DBV Technologies Recent Development

4.16 HAL Allergy

4.16.1 HAL Allergy Corporation Information

4.16.2 HAL Allergy Description, Business Overview

4.16.3 HAL Allergy Peanut Allergy Therapeutics Products Offered

4.16.4 HAL Allergy Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.16.5 HAL Allergy Peanut Allergy Therapeutics Revenue by Product in 2021

4.16.6 HAL Allergy Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.16.7 HAL Allergy Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.16.8 HAL Allergy Recent Development

4.17 Intrommune Therapeutics

4.17.1 Intrommune Therapeutics Corporation Information

4.17.2 Intrommune Therapeutics Description, Business Overview

4.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Products Offered

4.17.4 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)

4.17.5 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue by Product in 2021

4.17.6 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021

4.17.7 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue by Geographic Area in 2021

4.17.8 Intrommune Therapeutics Recent Development

5.1 Global Peanut Allergy Therapeutics Revenue by Type (2017-2022)

5.2 Global Peanut Allergy Therapeutics Revenue Forecast by Type (2023-2028)

5.3 Peanut Allergy Therapeutics Revenue Marke Share by Type (2017-2028)

6.1 Global Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)

6.2 Global Peanut Allergy Therapeutics Revenue Forecast by Distribution Channel (2023-2028)

6.3 Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2017-2028)

7.1 North America Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028

7.2 North America Peanut Allergy Therapeutics Market Facts & Figures by Country (2017-2028)

7.3 North America Peanut Allergy Therapeutics Revenue by Type (2017-2022)

7.4 North America Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)

8.1 Asia-Pacific Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028

8.2 Asia-Pacific Peanut Allergy Therapeutics Market Facts & Figures by Region (2017-2028)

8.3 Asia-Pacific Peanut Allergy Therapeutics Revenue by Type (2017-2022)

8.4 Asia-Pacific Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)

9.1 Europe Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028

9.2 Europe Peanut Allergy Therapeutics Market Facts & Figures by Country (2017-2028)

9.3 Europe Peanut Allergy Therapeutics Revenue by Type (2017-2022)

9.4 Europe Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)

10.1 Latin America Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028

10.2 Latin America Peanut Allergy Therapeutics Market Facts & Figures by Country (2017-2028)

10.3 Latin America Peanut Allergy Therapeutics Revenue by Type (2017-2022)

10.4 Latin America Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)

11.1 Middle East and Africa Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028

11.2 Middle East and Africa Peanut Allergy Therapeutics Market Facts & Figures by Country (2017-2028)

11.3 Middle East and Africa Peanut Allergy Therapeutics Revenue by Type (2017-2022)

11.4 Middle East and Africa Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)

12.1 Peanut Allergy Therapeutics Supply Chain Analysis

12.2 Peanut Allergy Therapeutics Key Raw Materials and Upstream Suppliers

12.3 Peanut Allergy Therapeutics Clients Analysis

12.4 Peanut Allergy Therapeutics Sales Channel and Sales Model Analysis

12.4.1 Peanut Allergy Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Peanut Allergy Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Peanut Allergy Therapeutics Distributors

13.1 Peanut Allergy Therapeutics Industry Trends

13.2 Peanut Allergy Therapeutics Market Drivers

13.3 Peanut Allergy Therapeutics Market Challenges

13.4 Peanut Allergy Therapeutics Market Restraints

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global Peanut Allergy Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Major Companies of Epinephrine Injection

    Table 3. Major Companies of Antihistamines

    Table 4. Major Companies of Oral Immunotherapy

    Table 5. Major Companies of Other

    Table 6. Global Peanut Allergy Therapeutics Market Size Growth by Distribution Channel (US$ Million): 2017 VS 2021 VS 2028

    Table 7. Global Peanut Allergy Therapeutics Market Size by Region (US$ Million): 2022 VS 2028

    Table 8. Global Peanut Allergy Therapeutics Revenue by Region (2017-2022) & (US$ Million)

    Table 9. Global Peanut Allergy Therapeutics Revenue Forecast by Region (2023-2028) & (US$ Million)

    Table 10. Peanut Allergy Therapeutics Revenue by Company (2017-2022) & (US$ Million)

    Table 11. Peanut Allergy Therapeutics Revenue Share by Company (2017-2022)

    Table 12. Ranking of Global Top Peanut Allergy Therapeutics Players by Revenue (US$ Million) in 2021

    Table 13. Global Peanut Allergy Therapeutics Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)

    Table 14. Global Peanut Allergy Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peanut Allergy Therapeutics as of 2021)

    Table 15. Global Peanut Allergy Therapeutics Companies Headquarters

    Table 16. Global Peanut Allergy Therapeutics Companies Product & Service

    Table 17. Date of International Companies Enter into Peanut Allergy Therapeutics Market

    Table 18. Global Peanut Allergy Therapeutics Mergers & Acquisitions, Expansion Plans

    Table 19. Mylan Corporation Information

    Table 20. Mylan Description and Business Overview

    Table 21. Mylan Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 22. Mylan Peanut Allergy Therapeutics Product

    Table 23. Mylan Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 24. Mylan Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 25. Mylan Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 26. Mylan Recent Development

    Table 27. Bayer Corporation Information

    Table 28. Bayer Description and Business Overview

    Table 29. Bayer Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 30. Bayer Peanut Allergy Therapeutics Product

    Table 31. Bayer Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 32. Bayer Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 33. Bayer Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 34. Bayer Recent Development

    Table 35. UCB Pharma Corporation Information

    Table 36. UCB Pharma Description and Business Overview

    Table 37. UCB Pharma Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 38. UCB Pharma Peanut Allergy Therapeutics Product

    Table 39. UCB Pharma Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 40. UCB Pharma Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 41. UCB Pharma Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 42. UCB Pharma Recent Development

    Table 43. J & J Corporation Information

    Table 44. J & J Description and Business Overview

    Table 45. J & J Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 46. J & J Peanut Allergy Therapeutics Product

    Table 47. J & J Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 48. J & J Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 49. J & J Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 50. J & J Recent Development

    Table 51. Perrigo Corporation Information

    Table 52. Perrigo Description and Business Overview

    Table 53. Perrigo Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 54. Perrigo Peanut Allergy Therapeutics Product

    Table 55. Perrigo Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 56. Perrigo Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 57. Perrigo Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 58. Perrigo Recent Development

    Table 59. GSK Corporation Information

    Table 60. GSK Description and Business Overview

    Table 61. GSK Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 62. GSK Peanut Allergy Therapeutics Product

    Table 63. GSK Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 64. GSK Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 65. GSK Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 66. Kaleo Corporation Information

    Table 67. Kaleo Description and Business Overview

    Table 68. Kaleo Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 69. Kaleo Peanut Allergy Therapeutics Product

    Table 70. Kaleo Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 71. Kaleo Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 72. Kaleo Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 73. Amneal Pharma Corporation Information

    Table 74. Amneal Pharma Description and Business Overview

    Table 75. Amneal Pharma Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 76. Amneal Pharma Peanut Allergy Therapeutics Product

    Table 77. Amneal Pharma Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 78. Amneal Pharma Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 79. Amneal Pharma Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 80. ALK Abello Corporation Information

    Table 81. ALK Abello Description and Business Overview

    Table 82. ALK Abello Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 83. ALK Abello Peanut Allergy Therapeutics Product

    Table 84. ALK Abello Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 85. ALK Abello Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 86. ALK Abello Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 87. Aimmune Therapeutics Corporation Information

    Table 88. Aimmune Therapeutics Description and Business Overview

    Table 89. Aimmune Therapeutics Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 90. Aimmune Therapeutics Peanut Allergy Therapeutics Product

    Table 91. Aimmune Therapeutics Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 92. Aimmune Therapeutics Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 93. Aimmune Therapeutics Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 94. HUAPONT Pharm Corporation Information

    Table 95. HUAPONT Pharm Description and Business Overview

    Table 96. HUAPONT Pharm Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 97. HUAPONT Pharm Peanut Allergy Therapeutics Product

    Table 98. HUAPONT Pharm Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 99. HUAPONT Pharm Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 100. HUAPONT Pharm Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 101. Allergy Therapeutics Corporation Information

    Table 102. Allergy Therapeutics Description and Business Overview

    Table 103. Allergy Therapeutics Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 104. Allergy Therapeutics Peanut Allergy Therapeutics Product

    Table 105. Allergy Therapeutics Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 106. Allergy Therapeutics Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 107. Allergy Therapeutics Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 108. ASIT Biotech Corporation Information

    Table 109. ASIT Biotech Description and Business Overview

    Table 110. ASIT Biotech Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 111. ASIT Biotech Peanut Allergy Therapeutics Product

    Table 112. ASIT Biotech Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 113. ASIT Biotech Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 114. ASIT Biotech Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 115. Sanofi Corporation Information

    Table 116. Sanofi Description and Business Overview

    Table 117. Sanofi Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 118. Sanofi Peanut Allergy Therapeutics Product

    Table 119. Sanofi Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 120. Sanofi Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 121. Sanofi Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 122. DBV Technologies Corporation Information

    Table 123. DBV Technologies Description and Business Overview

    Table 124. DBV Technologies Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 125. DBV Technologies Peanut Allergy Therapeutics Product

    Table 126. DBV Technologies Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 127. DBV Technologies Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 128. DBV Technologies Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 129. HAL Allergy Corporation Information

    Table 130. HAL Allergy Description and Business Overview

    Table 131. HAL Allergy Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 132. HAL Allergy Peanut Allergy Therapeutics Product

    Table 133. HAL Allergy Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 134. HAL Allergy Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 135. HAL Allergy Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 136. Intrommune Therapeutics Corporation Information

    Table 137. Intrommune Therapeutics Description and Business Overview

    Table 138. Intrommune Therapeutics Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 139. Intrommune Therapeutics Peanut Allergy Therapeutics Product

    Table 140. Intrommune Therapeutics Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Product in 2021

    Table 141. Intrommune Therapeutics Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Distribution Channel in 2021

    Table 142. Intrommune Therapeutics Peanut Allergy Therapeutics Revenue Proportion of Peanut Allergy Therapeutics by Geographic Area in 2021

    Table 143. Global Peanut Allergy Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 144. Global Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022) & (US$ Million)

    Table 145. Global Peanut Allergy Therapeutics Revenue Forecast by Distribution Channel (2023-2028) & (US$ Million)

    Table 146. North America Peanut Allergy Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 147. North America Peanut Allergy Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 148. North America Peanut Allergy Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 149. North America Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022) & (US$ Million)

    Table 150. Asia-Pacific Peanut Allergy Therapeutics Revenue by Region (2017-2028) & (US$ Million)

    Table 151. Asia-Pacific Peanut Allergy Therapeutics Revenue by Region (2023-2028) & (US$ Million)

    Table 152. Asia-Pacific Peanut Allergy Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 153. Asia-Pacific Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022) & (US$ Million)

    Table 154. Europe Peanut Allergy Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 155. Europe Peanut Allergy Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 156. Europe Peanut Allergy Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 157. Europe Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022) & (US$ Million)

    Table 158. Latin America Peanut Allergy Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 159. Latin America Peanut Allergy Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 160. Latin America Peanut Allergy Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 161. Latin America Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022) & (US$ Million)

    Table 162. Middle East and Africa Peanut Allergy Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 163. Middle East and Africa Peanut Allergy Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 164. Middle East and Africa Peanut Allergy Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 165. Middle East and Africa Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022) & (US$ Million)

    Table 166. Peanut Allergy Therapeutics Key Raw Materials, Industry Status and Trend

    Table 167. Peanut Allergy Therapeutics Key Raw Materials and Upstream Suppliers

    Table 168. Peanut Allergy Therapeutics Clients Status and Trend

    Table 169. Peanut Allergy Therapeutics Typical Clients

    Table 170. Peanut Allergy Therapeutics Distributors

    Table 171. Peanut Allergy Therapeutics Market Trends

    Table 172. Peanut Allergy Therapeutics Market Drivers

    Table 173. Peanut Allergy Therapeutics Market Challenges

    Table 174. Peanut Allergy Therapeutics Market Restraints

    Table 175. Research Programs/Design for This Report

    Table 176. Key Data Information from Secondary Sources

    Table 177. Key Data Information from Primary Sources

List of Figures

    Figure 1. Peanut Allergy Therapeutics Product Picture

    Figure 2. Global Peanut Allergy Therapeutics Revenue Market Share by Type in 2021 & 2028

    Figure 3. Epinephrine Injection Product Picture

    Figure 4. Antihistamines Product Picture

    Figure 5. Oral Immunotherapy Product Picture

    Figure 6. Other Product Picture

    Figure 7. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel in 2021 & 2028

    Figure 8. Hospital Pharmacy

    Figure 9. Retail Pharmacy

    Figure 10. Other

    Figure 11. Peanut Allergy Therapeutics Report Years Considered

    Figure 12. Global Peanut Allergy Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 13. Global Peanut Allergy Therapeutics Market Size 2017-2028 (US$ Million)

    Figure 14. Global Peanut Allergy Therapeutics Market Size Market Share by Region: 2022 Versus 2028

    Figure 15. Global Peanut Allergy Therapeutics Revenue Market Share by Region (2017-2028)

    Figure 16. Peanut Allergy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

    Figure 17. Global Peanut Allergy Therapeutics Revenue Market Share Forecast by Type (2017-2028)

    Figure 18. Global Peanut Allergy Therapeutics Revenue Market Share Forecast by Distribution Channel (2017-2028)

    Figure 19. North America Peanut Allergy Therapeutics Revenue 2017-2028 (US$ Million)

    Figure 20. North America Peanut Allergy Therapeutics Revenue Market Share by Type (2017-2022)

    Figure 21. North America Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2017-2022)

    Figure 22. Asia-Pacific Peanut Allergy Therapeutics Revenue 2017-2028 (US$ Million)

    Figure 23. Asia-Pacific Peanut Allergy Therapeutics Revenue Market Share by Region (2017-2028)

    Figure 24. Asia-Pacific Peanut Allergy Therapeutics Revenue Market Share by Type (2017-2022)

    Figure 25. Asia-Pacific Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2017-2022)

    Figure 26. Europe Peanut Allergy Therapeutics Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 27. Europe Peanut Allergy Therapeutics Revenue Market Share by Country (2017-2028)

    Figure 28. Europe Peanut Allergy Therapeutics Revenue Market Share by Type (2017-2022)

    Figure 29. Europe Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2017-2022)

    Figure 30. Latin America Peanut Allergy Therapeutics Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 31. Latin America Peanut Allergy Therapeutics Revenue Market Share by Country (2017-2022)

    Figure 32. Latin America Peanut Allergy Therapeutics Revenue Market Share by Type (2017-2022)

    Figure 33. Latin America Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2017-2022)

    Figure 34. Middle East and Africa Peanut Allergy Therapeutics Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 35. Middle East and Africa Peanut Allergy Therapeutics Revenue Market Share by Country (2017-2028)

    Figure 36. Middle East and Africa Peanut Allergy Therapeutics Revenue Market Share by Type (2017-2022)

    Figure 37. Middle East and Africa Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2017-2022)

    Figure 38. Peanut Allergy Therapeutics Supply Chain (Upstream and Downstream Market)

    Figure 39. Global Production Market Share of Peanut Allergy Therapeutics Raw Materials by Region in 2021

    Figure 40. Peanut Allergy Therapeutics Distribution Channels

    Figure 41. Global Peanut Allergy Therapeutics Percentage 2017-2028: Indirect Sales VS Direct Sales

    Figure 42. Global Peanut Allergy Therapeutics Percentage 2017-2028: Online Sales VS Offline Sales

    Figure 43. Bottom-up and Top-down Approaches for This Report

    Figure 44. Data Triangulation

    Figure 45. Key Executives Interviewed